KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

KORU Medical Systems, Inc.NASDAQ: KRMD

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization dips below year-ago levels

Q1 FY2026 depreciation & amortization of $197.53K fell 9.1% year over year, behind the +4.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 10.2% from the prior quarter. Over 3 fiscal years it compounded at +11.3% a year.

Context

  • Depreciation & amortization amounted to 2.0% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Depreciation & amortization increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -9.1% toward the trailing-twelve-month pace of +4.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$197.53K+10.2% QoQ
Last fiscal yearDec 2025
$810.5K+4.9% YoY
LTMMar 2026
$790.67K+4.2% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-9.1%——
1 year+4.9%——
3-year CAGR+11.3%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
810.5K USD
Year-over-year change
+4.9%
4-year CAGR
+15.0%

Depreciation & Amortization vs competitors

How KRMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +4.2% is the 5th highest of 10, against a peer median of +2.4%.
  • Depreciation & amortization amounts to 1.8% of revenue for KRMD, versus a peer median of 7.8%.
KRMD Competitors
Depreciation & Amortization for KRMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INFUInfuSystem Holdings, Inc.LTM Mar 2026$13.23M USD+2.4%-0.2%9.3%
OSUROraSure Technologies, Inc.LTM Mar 2026$9.54M USD+11.9%-10.7%8.4%
NYXHNyxoah S.A.LTM Mar 2026€5.27M EUR+149.9%+32.4%32.3%
MXCTMaxCyte, Inc.LTM Mar 2026$4.48M USD-11.7%+24.0%13.9%
PREPrenetics Global LimitedLTM Mar 2026$3.97M USD+79.9%-20.6%3.5%
STIMNeuronetics, Inc.LTM Mar 2026$3.3M USD+36.1%+28.1%2.2%
UTMDUtah Medical Products, Inc.LTM Mar 2026$2.93M USD+2.1%-25.3%7.8%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$790.67K USD+4.2%+11.3%1.8%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$589K USD-20.5%+14.8%1.3%
PROFProfound Medical Corp.LTM Mar 2026$499.7K USD-57.0%-29.2%2.6%
Peer median (excluding KRMD) —+2.4%-0.2%7.8%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.49M27.9M28.52M33.65M41.13M
Cost of Revenue9.72M12.53M11.81M12.31M15.52M
Gross Profit13.77M15.37M16.71M21.33M25.6M
Gross Margin58.6%55.1%58.6%63.4%62.3%
Research & Development2.47M4.96M5.74M5.26M4.39M
Selling, General & Admin000023.38M
Operating Expenses20.8M26.15M26.98M27.78M28.58M
Depreciation & Amortization463.13K587.14K870.39K772.89K810.5K
EBITDA(5.9M)(10.09M)(8.9M)(5.29M)(1.81M)
EBITDA Margin-25.1%-36.2%-31.2%-15.7%-4.4%
Operating Income(7.03M)(10.78M)(10.27M)(6.45M)(2.97M)
Operating Margin-29.9%-38.6%-36.0%-19.2%-7.2%
Interest Income13.08K145.59K561.33K444.64K293.4K
Interest Expense00000
Other Income / Expenses665.09K105.71K496.4K382.49K356.41K
Income Before Tax(6.36M)(10.68M)(9.77M)(6.06M)(2.62M)
Pre-Tax Margin-27.1%-38.3%-34.3%-18.0%-6.4%
Income Tax Expense(1.8M)(2.01M)3.97M2.89K21.89K
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Net Margin-19.4%-31.0%-48.2%-18.0%-6.4%
EPS (Basic)(0.10)(0.19)(0.30)(0.13)(0.06)
EPS (Diluted)(0.10)(0.19)(0.30)(0.13)(0.06)
Weighted Avg Shares44.39M45M45.6M45.8M46.19M
Weighted Avg Shares (Diluted)44.39M45M45.6M45.8M46.19M

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.